One of MedicaSafe’s primary goals is to develop products for high-risk medication management. So it makes sense for the New York-based company to focus on opioid addiction, which claims the lives of more than 130 people every day in the U.S. (According to the U.S. Department of Health and Human Services).
The New York-based company recently received $1 million Small Business Innovation Research grant from the National Institute of Health, with a specific focus on opioid use disorder (OUD).
The funding will support a clinical trial to examine the effect of MedicaSafe’s drug-device combination vs. standard of care in the treatment management of OUD. The trial is conducted to determine whether the system can help foster treatment compliance and assist clini…
MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
